Novartis Transderm Scop Superiority Claim Disputed In Pharmacia Petition
This article was originally published in The Tan Sheet
Executive Summary
Pharmacia is asking FDA to modify the physician package insert for Novartis' Transderm Scop Rx motion sickness patch to remove a statement claiming superiority to OTC oral dimenhydrinate.